The questions that surface post-deal
Following acquisitions, we consistently hear the same questions from corporate functions, business owners, operations and IT leaders:
These questions often appear technical in nature. In reality, they point to something much deeper.
The real issue: process without a blueprint
Most post-deal challenges stem from fragmented operating models.
Over time, ERP systems, particularly SAP, become a patchwork of:
Without a clear process blueprint, acquisitions force organisations into false choices:
Too often, the default answer is simply to force adoption of existing processes, without validating whether they are actually fit for purpose.
One size does not fit all
There is a persistent belief that standardisation means ignoring the realities of different businesses. In practice, the opposite is true.
Effective process integration starts by understanding:
Not every process should be identical. But every process should be intentional.
The human factor in process integration
While ERP systems and process blueprints are essential, research shows that most M&A failures stem from cultural and people-related issues, not technical challenges. Even the most robust processes fail if teams resist change or lack clarity on new ways of working.
Three critical cultural risks emerge during life sciences M&A:
To mitigate these risks, organisations should:
Companies that address culture alongside systems achieve faster integration and higher employee retention post-deal.
Reinvention is rarely the answer
Post-deal integration does not require starting from scratch.
The opportunity lies in:
This approach avoids both extremes: blind replication and unnecessary reinvention.
ERP should enable scale not constrain it
When ERP is used as an integration shortcut rather than a strategic enabler, complexity multiplies.
Organisations that scale successfully treat ERP as a platform for process clarity, not a dumping ground for inherited ways of working. They invest upfront in defining how the business should operate, before deciding how systems should support it.
The opportunity: Turning integration into advantage
Growth and M&A don’t break processes. They reveal whether an organisation truly understands its operating model and strategic intent. The difference between those that struggle and those that thrive lies in how they approach integration.
Life sciences organisations that treat M&A as a catalyst for operational clarity—not just growth—outperform their peers. They use integration to:
A litmus test for leaders:
The best-prepared firms don’t just survive integration; they use it to redefine how they compete. By addressing culture, technology, and strategy in tandem, they integrate faster, scale smarter, and realise value sooner after a deal.
Through planning and due diligence to
execution and stabilisation
Understanding the levers for
successful integration
Expertly navigate the challenges and
risks
Unpick the opportunities to drive the
bottom line

Disentangling a well-established site from a complex corporate infrastructure-with stringent timelines, local compliance challenges, and a rigid transitional services agreement (TSA) in place.
Expertly navigate the challenges and
risks.
Combining processes, systems and
people to deliver maximum results
Working with what you've got to make
things even better

How we streamlined and future-proofed, a soon-to-be obsolete labelling solution and a rapid client expansion across multiple new sites.
Enhancing decision making and strategic
alignment to drive performance
Using the latest technology to drive efficiencies, innovation and operational excellence
Meeting local requirements while
delivering smooth cross-border
operations
Simplifying supply chain finance
Improving compliance accuracy and
automation using tax technology